{"id":4238,"date":"2025-12-01T20:15:43","date_gmt":"2025-12-01T17:15:43","guid":{"rendered":"https:\/\/auxsupport.com\/?p=4238"},"modified":"2025-12-08T13:54:19","modified_gmt":"2025-12-08T10:54:19","slug":"testa-sopa-genetiki-ya-kansere","status":"publish","type":"post","link":"https:\/\/auxsupport.com\/ku\/testa-sopa-genetiki-ya-kansere\/","title":{"rendered":"\u015eopandina genet\u00eek\u00ee ya pence\u015f\u00ear\u00ea: Raporek p\u00ea\u015fkeft\u00ee \u00fb berfireh ji bo t\u00eagih\u00ee\u015ftina rast a dermankirina hedefgirt\u00ee"},"content":{"rendered":"<h1 class=\"wp-block-heading\"><strong>p\u00ea\u015fgotin<\/strong><\/h1>\n\n\n\n<p class=\"wp-block-paragraph\">Di serdema tibb\u00ea \u015fexs\u00ee de, \u00ead\u00ee ne mimkun e ku meriv bi nexwe\u015fiyan re mij\u00fbl bibe. <a href=\"https:\/\/auxsupport.com\/ku\/turizma-bijiski-li-urdune\/\" data-type=\"page\" data-id=\"3885\">qans\u00ear <\/a>Ew bi ten\u00ea xwe disp\u00eare te\u015fh\u00eesa kl\u00een\u00eek\u00ee. P\u00ea\u015fketin\u00ean di genom\u00eek \u00fb genet\u00eek\u00ea de \u015fore\u015fek di v\u00ee war\u00ee de \u00e7\u00eakirine, \u00fb \u015fopa tiliy\u00ean genet\u00eek\u00ee, an j\u00ee ceribandina genet\u00eek\u00ee ya pence\u015f\u00ear\u00ea, kiriye yek ji tekn\u00eek\u00ean bij\u00ee\u015fk\u00ee y\u00ean her\u00ee gir\u00eeng \u00fb p\u00ea\u015fket\u00ee di te\u015fh\u00ees \u00fb dermankirina tumoran de. Ev ceribandin xwe disp\u00eare anal\u00eeza DNA-y\u00ea ya pir rast da ku mutasyon\u00ean genet\u00eek\u00ee y\u00ean berpirsiyar\u00ea p\u00ea\u015fve\u00e7\u00fbna pence\u015f\u00ear\u00ea an j\u00ee y\u00ean ku xetera p\u00ea\u015fve\u00e7\u00fbna w\u00ea z\u00eade dikin tesp\u00eet bike, bi v\u00ee away\u00ee der\u00ee li ber stratejiy\u00ean dermankirin\u00ea y\u00ean bibandortir \u00fb kesanetir vedike.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Gir\u00eengiya v\u00ea test\u00ea \u00eero di rola w\u00ea ya gir\u00eeng de ye di r\u00eaberiya te\u015fh\u00eesa rast, destn\u00ee\u015fankirina dermankirina her\u00ee guncaw ji bo her nexwe\u015fek takekes\u00ee, \u00fb p\u00ea\u015fb\u00een\u00eekirina bersiva tumor\u00ea ji bo dermankirin\u00ea. V\u00ea yek\u00ea karan\u00eena w\u00ea kiriye be\u015fek gir\u00eeng a protokol\u00ean gerd\u00fbn\u00ee di onkolojiya n\u00fbjen de. Ev gotar r\u00eabernameya we ya berfireh e ji bo t\u00eagih\u00ee\u015ftina ka testa genet\u00eek\u00ee \u00e7i ye, tekn\u00eek\u00ean w\u00ea y\u00ean p\u00ea\u015fkeft\u00ee, c\u00fbdahiy\u00ean di navbera celeb\u00ean w\u00ea de, \u00fb rola w\u00ea ya gir\u00eeng di ba\u015ftirkirina encam\u00ean nexwe\u015f\u00ean pence\u015f\u00ear\u00ea de.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/auxsupport.com\/wp-content\/uploads\/2025\/12\/KJJSM52HC02BpZQkQKsGHi5oeFA3hugFl2pocVGs-1024x512.jpg\" alt=\"DNA\" class=\"wp-image-4592\" title=\"\"><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">\u015eopandina fingerprint\u00ea ya genet\u00eek\u00ee (anal\u00eeza genet\u00eek\u00ee ya tumoran) \u00e7i ye?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u015eopandina tiliy\u00ean genet\u00eek\u00ee, an j\u00ee **anal\u00eeza genet\u00eek\u00ee ya tumor\u00ea**, anal\u00eezek p\u00ea\u015fket\u00ee ye ku armanc dike ku mutasyon\u00ean genet\u00eek\u00ee y\u00ean di nav hucrey\u00ean pence\u015f\u00ear\u00ea de an j\u00ee di hucrey\u00ean saxlem \u00ean la\u015f de l\u00eakol\u00een bike. Ev mutasyon mezinb\u00fbn \u00fb belavb\u00fbna tumor\u00ea r\u00eaber dikin \u00fb lawaziy\u00ean w\u00ea destn\u00ee\u015fan dikin. Ev mutasyon\u00ean genet\u00eek\u00ee dikarin li du celeb\u00ean sereke werin dabe\u015f kirin:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Mutasyon\u00ean m\u00eerat\u00ee:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ev mutasyon ji d\u00ea\u00fbbavan t\u00ean veguhastin \u00fb di her \u015faneyek la\u015f de t\u00eane d\u00eetin. Ev mutasyon ne hewce ye ku were wateya ku pence\u015f\u00ear d\u00ea p\u00ea\u015f bikeve, l\u00ea ew bi gir\u00eeng\u00ee xetera p\u00ea\u015fxistina pence\u015f\u00ear\u00ea z\u00eade dikin. Nim\u00fbney\u00ean her\u00ee gelemper\u00ee mutasyon\u00ean di gen\u00ean BRCA1 \u00fb BRCA2 de ne, ku bi tund\u00ee bi z\u00eadeb\u00fbna xetera pence\u015f\u00eara memik, h\u00eakdank, prostat \u00fb pankreas\u00ea ve gir\u00eaday\u00ee ne.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Mutasyon\u00ean bidestxist\u00ee (Mutasyon\u00ean Somat\u00eek):<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ev mutasyon di DNAya \u015faneyek an komek \u015faneyan de di jiyana mirovek\u00ee de wek\u00ee encamek ji ber r\u00fbbir\u00fbb\u00fbna r\u00eazek faktor\u00ean haw\u00eerdor\u00ee an navxwey\u00ee \u00e7\u00eadibin. Van faktoran cixarek\u00ea\u015fandin, k\u00eemyew\u00ee, t\u00eer\u00eaj\u00ean ultraviyole, an xeletiy\u00ean ku di dema dabe\u015fb\u00fbna \u015faney\u00ea de \u00e7\u00eadibin vedihew\u00eene. Ev mutasyon ew in ku dibin sedema p\u00ea\u015fve\u00e7\u00fbna tumor\u00ea \u00fb armanca sereke ya dermankirina pence\u015f\u00ear\u00ea ya hedefgirt\u00ee ne.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Testkirina genet\u00eek\u00ee armanc dike ku van mutasyonan, \u00e7i m\u00eeras\u00ee bin \u00e7i bi dest xist\u00ee, nas bike da ku nex\u015feyek rast a tumor\u00ea peyda bike.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Armanc\u00ean sereke y\u00ean ceribandina genet\u00eek\u00ee ji bo pence\u015f\u00ear\u00ea<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Armanca ceribandina genet\u00eek\u00ee ji te\u015fh\u00eesa kevne\u015fop\u00ee w\u00eadetir di\u00e7e, \u00fb t\u00eagih\u00ee\u015ftin\u00ean gir\u00eeng peyda dike ku bandor\u00ea li tevahiya plana dermankirin\u00ea dikin. Armanc\u00ean sereke y\u00ean **ceribandina genet\u00eek\u00ee ya pence\u015f\u00ear\u00ea** ev in:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. Terapiya Armanckir\u00ee:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Hilbijartina Terapiya Armanckir\u00ee:** Testkirin mutasyon\u00ean genet\u00eek\u00ee destn\u00ee\u015fan dike ku dikarin bi derman\u00ean taybet\u00ee werin hedefgirtin da ku mezinb\u00fbna hucrey\u00ean pence\u015f\u00ear\u00ea b\u00eay\u00ee ku zirar\u00ea bidin hucrey\u00ean saxlem rawest\u00eenin. M\u00eenak\u00ee, tesp\u00eetkirina mutasyonek EGFR di pence\u015f\u00eara pi\u015fik\u00ea de bij\u00ee\u015fk r\u00eaber dike ku astengker\u00ean EGFR bikar b\u00eene.<\/li>\n\n\n\n<li>**Diyar kirina bersiva ji bo \u00eem\u00fbnoterapiy\u00ea:** Hin mutasyon an n\u00ee\u015fanker\u00ean b\u00ea\u00eest\u00eeqrariya genom\u00eek (wek TMB \u00fb MSI) diyar dikin ka nexwe\u015fek d\u00ea ji \u00eem\u00fbnoterapiy\u00ea s\u00fbd werbigire an na.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">2. P\u00ea\u015fb\u00een\u00eekirina tevger\u00eena tumor\u00ea (Prognoz):<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**P\u00ea\u015fb\u00een\u00eekirina r\u00ea\u00e7a p\u00ea\u015feroj\u00ea ya nexwe\u015fiy\u00ea:** Muayene di p\u00ea\u015fb\u00een\u00eekirina tevger\u00eena tumor\u00ea de dibe al\u00eekar, gelo ew \u00ea \u00ear\u00ee\u015fkar \u00fb bi lez belav bibe an j\u00ee h\u00ead\u00ee mezin bibe.<\/li>\n\n\n\n<li>**P\u00ea\u015fb\u00een\u00eekirina bersiva nexwe\u015fan ji dermanan re:** Ev di destn\u00ee\u015fankirina \u00eeht\u00eemala bersiva nexwe\u015fek ji kemoterap\u00ee an j\u00ee radyoterapiy\u00ea de dibe al\u00eekar, bi v\u00ee away\u00ee dermankirin\u00ean nehewce \u00fb bandor\u00ean al\u00ee y\u00ean t\u00eakildar k\u00eam dibin.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">3. L\u00eakol\u00eena r\u00eeska pence\u015f\u00eara m\u00eeras\u00ee:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Cudahiya di navbera pence\u015f\u00eara m\u00eeras\u00ee \u00fb ne-mras\u00ee de:** Muayene dibe al\u00eekar ku were destn\u00ee\u015fankirin ka enfeksiyon ji ber mutasyoneke genet\u00eek\u00ee ye ku dikare ji endam\u00ean malbat\u00ea re were veguhastin.<\/li>\n\n\n\n<li>**R\u00eavebirina R\u00eesk\u00ea:** Dest\u00fbr\u00ea dide xizm\u00ean di xeterey\u00ea de ku tedb\u00eer\u00ean p\u00ea\u015f\u00eel\u00eagirtin\u00ea bigirin, wek m\u00eenak kontrolkirina z\u00fb ya dubare an j\u00ee emeliyata p\u00ea\u015f\u00eel\u00eagirtin\u00ea.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Gav\u00ean berfireh ji bo p\u00eakan\u00eena testa \u015fopa genet\u00eek\u00ee<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">P\u00eavajoya **\u015fopa tiliy\u00ean genet\u00eek\u00ee** tevlihev \u00fb rast e, \u00fb di laboratuar\u00ean pispor de p\u00eak t\u00ea. Her \u00e7end r\u00eabaza berhevkirina nim\u00fbneyan c\u00fbda be j\u00ee, p\u00eavajoya laboratuar\u00ea gav\u00ean standard di\u015fop\u00eene:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. Berhevkirin \u00fb kal\u00eeteya nim\u00fbneyan: Nim\u00fbne bingeha rastb\u00fbn\u00ea ye.<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Nim\u00fbne bi gelemper\u00ee bi du away\u00ean sereke t\u00ea berhevkirin:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Biyopsiya Te\u015feyan:** Ev r\u00eabaza her\u00ee gelemper\u00ee \u00fb terc\u00eehkir\u00ee ye ji bo rastb\u00fbna seretay\u00ee. Nim\u00fbneyek pi\u00e7\u00fbk rasterast ji tumor\u00ea t\u00ea girtin, \u00fb ev nim\u00fbne ji bo anal\u00eeza genet\u00eek\u00ee ya rasterast a \u015faney\u00ean pence\u015f\u00ear\u00ea t\u00ea bikar an\u00een.<\/li>\n\n\n\n<li>**Biyopsiya \u015eile:** Di anal\u00eeza DNAya azad a di gera xw\u00een\u00ea de (cfDNA) an j\u00ee DNAya tumor\u00ea ya di gera xw\u00een\u00ea de (ctDNA) t\u00ea bikaran\u00een.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">2. Derxistina DNAy\u00ea:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ev qonax ji bo misogerkirina kal\u00eeteya anal\u00eez\u00ea gir\u00eeng e. DNA ji \u015faneyan an j\u00ee ji plazmay\u00ea (di rew\u015fa testa xw\u00een\u00ea de) bi karan\u00eena tekn\u00eek\u00ean laborat\u00eef \u00fb k\u00eemyew\u00eey\u00ean rast \u00ean ku armanc dikin ku m\u00eeqdarek t\u00ear \u00fb paqij a DNA-y\u00ea were bidestxistin, t\u00ea veqetandin.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3. Anal\u00eeza genet\u00eek\u00ee \u00fb bikaran\u00eena tekn\u00eek\u00ean p\u00ea\u015fket\u00ee y\u00ean NGS<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Rastb\u00fbna ceribandina genet\u00eek\u00ee bi teknolojiya ku ji bo xwendina r\u00eaza genet\u00eek\u00ee t\u00ea bikar an\u00een ve gir\u00eaday\u00ee ye. Li vir e ku teknolojiy\u00ean n\u00fbjen dikevin dewr\u00ea:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Teknolojiya R\u00eazkirina Nif\u015f\u00ea N\u00fb (NGS)<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Teknolojiya NGS wek\u00ee standarda z\u00ear\u00een ji bo anal\u00eeza genet\u00eek\u00ee ya berfireh t\u00ea hesibandin. Ev teknolojiya p\u00ea\u015fket\u00ee r\u00ea dide van ti\u015ftan:**<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Tesb\u00eetkirina Berfireh:** Di yek anal\u00eez\u00ea de bi sedan gen di carek\u00ea de tesp\u00eet dike (Panel\u00ean Genan).<\/li>\n\n\n\n<li>**Lez \u00fb Rastb\u00fbn:** R\u00eazkirina DNA dikare bi leza bilind \u00fb bi l\u00ea\u00e7\u00fbnek k\u00eamtir ji ber\u00ea were xwendin.<\/li>\n\n\n\n<li>**Ved\u00eetina mutasyon\u00ean nadir:** \u015e\u00eeyana w\u00ea ya tesp\u00eetkirina mutasyon\u00ean genet\u00eek\u00ee y\u00ean nadir an n\u00fb ku dibe ku ji h\u00eala teknolojiy\u00ean kevin ve ney\u00ean tesp\u00eet kirin.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Teknolojiya reaksiyona zinc\u00eera pol\u00eemeraz (PCR)<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Ew ji bo tesp\u00eetkirina mutasyon\u00ean taybet\u00ee, y\u00ean ku ber\u00ea dihatin zan\u00een, wek yek an du, t\u00ea bikar an\u00een. Ew bilez e \u00fb ji bo rew\u015f\u00ean ku encamek bilez hewce dikin an j\u00ee dema ku armanc l\u00eager\u00eena mutasyonek p\u00ea\u015fb\u00een\u00eekir\u00ee ye guncaw e.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">4. Xwendina encaman \u00fb \u015f\u00eerovekirina rapora daw\u00ee<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Pi\u015ft\u00ee ku p\u00eavajoya r\u00eazkirin\u00ea qediya, m\u00eeqdara mezin a daney\u00ean genet\u00eek\u00ee bi karan\u00eena bernamey\u00ean komputer\u00ea y\u00ean taybet\u00ee (Bioinformatics) t\u00eane anal\u00eezkirin.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Berawirdkirina Databas\u00ea:** Genot\u00eepa nexwe\u015f bi set\u00ean daney\u00ean gerd\u00fbn\u00ee y\u00ean mezin (wek set\u00ean daney\u00ean COSMIC \u00fb ClinVar) re t\u00ea berhevdan da ku bandora mutasyona tesp\u00eetkir\u00ee li ser fonksiyona prote\u00een\u00ea \u00fb t\u00eakiliya w\u00ea bi nexwe\u015fiy\u00ea re were destn\u00ee\u015fankirin.<\/li>\n\n\n\n<li>**\u015e\u00eerovekirina rapora daw\u00ee:** Ev gav ji h\u00eala onkolog an j\u00ee genet\u00eeknas ve t\u00ea kirin. Mutasyon\u00ean ku hatine tesp\u00eetkirin bi **te\u015fh\u00eesa rast**, **plana dermankirina armanckir\u00ee**, \u00fb **p\u00ea\u015fb\u00eeniy\u00ea** ve gir\u00eaday\u00ee ne.<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/auxsupport.com\/wp-content\/uploads\/2025\/12\/dna-lab.jpg\" alt=\"\" class=\"wp-image-4593\" title=\"\"><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">C\u00fbdahiya bingeh\u00een di navbera ceribandina gena xw\u00een\u00ea (Biyopsiya \u015eile) \u00fb ceribandina tevn\u00ea de<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">C\u00fbdahiya di navbera test\u00ean xw\u00een\u00ea \u00fb test\u00ean tevn\u00ea de aliyek gir\u00eeng e ku dema anal\u00eeza genet\u00eek\u00ee ya tumoran t\u00ea kirin div\u00ea were f\u00eam kirin. Her yek ji wan xwed\u00ee rol \u00fb avantaj\u00ean xwe ye.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Yekem: Testa xw\u00een\u00ea (Biyopsiya \u015eile) - Anal\u00eeza ne-dagirker<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">**Testa gen\u00ean xw\u00een\u00ea** li ser bingeha anal\u00eeza DNAya \u015faney\u00ean pence\u015f\u00ear\u00ea y\u00ean di gera xw\u00een\u00ea de (ctDNA) ye, ku bi mirin an j\u00ee riz\u00eeb\u00fbna \u015faney\u00ean pence\u015f\u00ear\u00ea ve t\u00ea berdan.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Taybetmendiy\u00ean sereke:**\n<ul class=\"wp-block-list\">\n<li>**H\u00easan, bilez \u00fb b\u00ea \u00ea\u015f:** P\u00eadiv\u00ee bi ti emeliyat an anesteziy\u00ea nake, \u00fb ji bo nexwe\u015f\u00ean qels an j\u00ee kes\u00ean ku ji nexwe\u015fiy\u00ean din diki\u015f\u00eenin \u00eedeal e.<\/li>\n\n\n\n<li>**\u00c7avd\u00eariya P\u00ea\u015fve\u00e7\u00fbna Nexwe\u015fiy\u00ea:** Ev ji bo \u015fopandina p\u00ea\u015fve\u00e7\u00fbna nexwe\u015fiy\u00ea \u00fb bersiva dermankirin\u00ea pir bik\u00earhat\u00ee ye, ji ber ku ew dikare dubare were kirin da ku derketina hol\u00ea ya mutasyon\u00ean berxwedan\u00ea y\u00ean n\u00fb were tesp\u00eet kirin.<\/li>\n\n\n\n<li>**Ji biyopsiy\u00ean dijwar d\u00fbr bisekinin:** Ji bo nexwe\u015f\u00ean ku biyopsiya wan dijwar e, nemaze di rew\u015f\u00ean tumor\u00ean hest\u00ee an m\u00eaj\u00ee de, \u00eedeal e.<\/li>\n\n\n\n<li>**Tesb\u00eetkirina Nehevsengiya Tumor\u00ea:** Ev guhertin\u00ean di tumor\u00ea de bi dem\u00ea re \u00fb li dever\u00ean c\u00fbda y\u00ean belavb\u00fbna w\u00ea n\u00ee\u015fan dide.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>**S\u00eenorkirin (K\u00eamas\u00ee):**\n<ul class=\"wp-block-list\">\n<li>Dibe ku ew hem\u00fb mutasyonan tesp\u00eet neke, nemaze heke m\u00eeqdara DNAya pence\u015f\u00ear\u00ea pir pi\u00e7\u00fbk be, wek\u00ee di pence\u015f\u00ear\u00ean destp\u00eak\u00ea de.<\/li>\n\n\n\n<li>Di qonax\u00ean pir z\u00fb de, li gor\u00ee muayeneya tevn\u00ea, di destn\u00ee\u015fankirina taybetmendiy\u00ean tumor\u00ea de k\u00eamtir rast e.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Duyem: Biyopsiya Te\u015feyan - Standarda Z\u00ear\u00een<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">**Muayeneya tevn\u00ea** li ser bingeha muayeneya \u015faney\u00ean pence\u015f\u00ear\u00ea rasterast ji tumora seretay\u00ee an j\u00ee metastazan e.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Taybetmendiy\u00ean sereke:**\n<ul class=\"wp-block-list\">\n<li>**Testeke genet\u00eek\u00ee ya her\u00ee rast a heta niha:** Ew her\u00ee z\u00eade m\u00eeqdara DNAya tumor\u00ea peyda dike, \u00fb rastb\u00fbna her\u00ee bilind misoger dike.<\/li>\n\n\n\n<li>**Taybetmendiy\u00ean tevah\u00ee y\u00ean tumor\u00ea e\u015fkere dike:** Ji bo anal\u00eeza panela gen\u00ea ya berfireh \u00fb tesp\u00eetkirina n\u00ee\u015fanker\u00ean tevlihev \u00ean wek\u00ee mutasyon\u00ean hevgirtin\u00ea ku di xw\u00een\u00ea de tesp\u00eetkirina wan dijwar e guncaw e.<\/li>\n\n\n\n<li>**Te\u015fh\u00eesa destp\u00eak\u00ea:** Ev r\u00eabaza bijarte ye ji bo te\u015fh\u00eesa destp\u00eak\u00ea ya nexwe\u015fiy\u00ea.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>**S\u00eenorkirin (K\u00eamas\u00ee):**\n<ul class=\"wp-block-list\">\n<li>Ew p\u00eadiv\u00ee bi emeliyateke bi\u00e7\u00fbk (biyops\u00ee) heye, ku dibe ku bibe sedema \u00ea\u015f an tevl\u00eeheviy\u00ean bi\u00e7\u00fbk.<\/li>\n\n\n\n<li>Carinan dibe ku nim\u00fbne ji bo anal\u00eezek tevah\u00ee t\u00ear\u00ea neke (Naveroka Tumor\u00ea T\u00ear\u00ea Nake).<\/li>\n\n\n\n<li>Ji bo \u015fopandina bersiva dermankirin\u00ea, dubarekirina w\u00ea bi h\u00easan\u00ee nay\u00ea kirin.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Keng\u00ea ba\u015ftir e ku meriv w\u00eaneya genet\u00eek\u00ee ya tiliya xwe bike?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Testkirina genet\u00eek\u00ee di gelek rew\u015fan de b\u00fbye p\u00eadiv\u00eeyek bij\u00ee\u015fk\u00ee, \u00fb ne ten\u00ea bi nexwe\u015f\u00ean bi pence\u015f\u00eara p\u00ea\u015fket\u00ee ve s\u00eenordar e. Testkirin di rew\u015f\u00ean j\u00ear\u00een de t\u00ea p\u00ea\u015fniyar kirin:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. Rew\u015f\u00ean gumanbar \u00ean pence\u015f\u00eara m\u00eerat\u00ee:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**D\u00eerokeke xurt a pence\u015f\u00ear\u00ea di malbat\u00ea de:** Bi taybet\u00ee heke nexwe\u015f\u00ee di \u00e7end nif\u015fan de an j\u00ee di gelek endam\u00ean malbat\u00ea de derketibe hol\u00ea.<\/li>\n\n\n\n<li>Ev nexwe\u015f\u00ee di temen\u00ea ciwaniy\u00ea de xuya dike: bi taybet\u00ee ber\u00ee p\u00eanc\u00ee sal\u00ee.<\/li>\n\n\n\n<li>**Pence\u015f\u00ear\u00ean k\u00eam an j\u00ee pir-tevn**.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">2. Plansaziya dermankirin\u00ea ji bo pence\u015f\u00ear\u00ean hevpar:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Testkirina genet\u00eek\u00ee ber\u00ee destp\u00eakirina her terapiya hedefgirt\u00ee gir\u00eeng e, nemaze di kanser\u00ean ku l\u00eakol\u00eenan n\u00ee\u015fan dane ku rasterast bi mutasyon\u00ean hedefgirt\u00ee ve gir\u00eaday\u00ee ne:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Kansera pi\u015fik\u00ea:** Ji bo tesp\u00eetkirina mutasyon\u00ean di *EGFR*, *ALK*, *ROS1* \u00fb y\u00ean din de.<\/li>\n\n\n\n<li>**Pence\u015f\u00eara Kolon \u00fb Rektal:** Ji bo l\u00eager\u00eena mutasyon\u00ean *KRAS*, *NRAS*, \u00fb *BRAF*.<\/li>\n\n\n\n<li>**Pence\u015f\u00eara Memik\u00ea:** Ji bo l\u00eager\u00eena mutasyon\u00ean genet\u00eek\u00ee \u00fb y\u00ean bidestxist\u00ee y\u00ean *HER2* \u00fb *BRCA*.<\/li>\n\n\n\n<li>**Kansera \u00c7erm (Melanoma):** Ji bo l\u00eager\u00eena mutasyona *BRAF*.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">3. Rew\u015f\u00ean berxwedana dermankirin\u00ea:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Dema ku nexwe\u015f bersiva dermankirina kevne\u015fop\u00ee nade:** Ger kemoterap\u00ee an radyoterap\u00ee ya kevne\u015fop\u00ee bi ser nekevin, ceribandina genet\u00eek\u00ee dikare r\u00eaberiya karan\u00eena xeta dermankirina n\u00fb ya hedefgirt\u00ee bike.<\/li>\n\n\n\n<li>**Di rew\u015fa dubareb\u00fbn\u00ea de:** Ji bo ji n\u00fb ve nirxandina mutasyonan, dibe ku hucrey\u00ean pence\u015f\u00ear\u00ea mutasyonek berxwedan\u00ea ya n\u00fb p\u00ea\u015fxistibin.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Rastb\u00fbn \u00fb p\u00eabaweriya ceribandina \u015fopa tiliy\u00ean genet\u00eek\u00ee (Gelo encam rast in?)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Rastb\u00fbna ceribandina genet\u00eek\u00ee ya ji bo pence\u015f\u00ear\u00ea di nav te\u015fh\u00ees\u00ean bij\u00ee\u015fk\u00ee y\u00ean n\u00fbjen de di nav y\u00ean her\u00ee bilind de ye. Bij\u00ee\u015fk\u00ean li \u00e7araliy\u00ea c\u00eehan\u00ea p\u00ea ve gir\u00eaday\u00ee ne ji ber ku ew daney\u00ean hem hejmar\u00ee \u00fb hem j\u00ee kal\u00eetey\u00ee li ser guhertin\u00ean genet\u00eek\u00ee peyda dike, ne ku ten\u00ea bi taybetmendiy\u00ean fenotip\u00eek \u00ean \u015faneyan ve gir\u00eaday\u00ee ye.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Teknolojiya NGS \u00fb garantiya p\u00eabaweriy\u00ea:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Dema ku teknolojiya NGS ya n\u00fbjen t\u00ea bikar an\u00een, nemaze li ser nim\u00fbney\u00ean tevn\u00ean bi kal\u00eete bilind, rastb\u00fbna tesp\u00eetkirina mutasyon\u00ea digih\u00eeje ast\u00ean pir ba\u015f. Di test\u00ean xw\u00een\u00ea de j\u00ee ba\u015fb\u00fbnek gir\u00eeng di rastb\u00fbn\u00ea de hatiye d\u00eetin \u00fb naha bi awayek\u00ee p\u00eabawer ji bo \u00e7avd\u00eariya nexwe\u015fiy\u00ea \u00fb tesp\u00eetkirina z\u00fb ya dubareb\u00fbna nexwe\u015fiy\u00ea t\u00eane bikar an\u00een.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Bandora rastb\u00fbn\u00ea li ser biryar\u00ean dermankirin\u00ea:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">L\u00eakol\u00een\u00ean berfireh n\u00ee\u015fan didin ku ceribandina genet\u00eek\u00ee di navbera biryar\u00ean dermankirin\u00ea y\u00ean 70% \u00fb 80% de di kanser\u00ean n\u00fbjen de r\u00eaberiy\u00ea dike. Ev t\u00ea v\u00ea watey\u00ea ku biryara guhertina celeb\u00ea dermankirin\u00ea, z\u00eadekirina terapiya hedefgirt\u00ee, an j\u00ee ketina ceribandinek kl\u00een\u00eek\u00ee rasterast bi encam\u00ean v\u00ea ceribandin\u00ea ve gir\u00eaday\u00ee ye.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Di gelek rew\u015fan de, ceribandina genet\u00eek\u00ee sedemek rasterast a **ba\u015ftirkirina encam\u00ean dermankirin\u00ea \u00fb z\u00eadeb\u00fbna r\u00eajey\u00ean ba\u015fb\u00fbn\u00ea** ye, ji ber ku ew pi\u015ftrast dike ku nexwe\u015f dermankirina ku bi taybet\u00ee ji bo mutasyon\u00ean di tumora wan de hene hat\u00ee \u00e7\u00eakirin werdigire.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">H\u00eaz\u00ean sereke \u00fb rola p\u00ea\u015feroj\u00ea ya anal\u00eeza genet\u00eek\u00ee<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">**Anal\u00eeza Genet\u00eek\u00ee ya Tumor\u00ea** h\u00eaza ajotin\u00ea ya Derman\u00ea Precision tems\u00eel dike, \u00fb xal\u00ean w\u00ea y\u00ean bih\u00eaz di y\u00ean j\u00ear\u00een de diyar in:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. \u00c7alakkirina Terapiya Armanckir\u00ee:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ew di hilbijartina dermankirinek rast de ku ji bo mutasyona gena taybet\u00ee armanc dike dibe al\u00eekar, ku bandora dermankirin\u00ea z\u00eade dike \u00fb bandor\u00ean aliy\u00ee y\u00ean giran k\u00eam dike.<\/li>\n\n\n\n<li>Ew dermankirina nehewce k\u00eam dike ku nexwe\u015f d\u00ea j\u00ea s\u00fbd wernegire, dem, hewldan \u00fb \u00e7avkaniyan teser\u00fbf dike.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">2. \u00c7avd\u00eariya berfireh a nexwe\u015fiy\u00ea:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ew di \u015fopandina nexwe\u015fiy\u00ea \u00fb destn\u00ee\u015fankirina \u00eeht\u00eemala dubareb\u00fbna w\u00ea de pi\u015ft\u00ee demek dir\u00eaj ji dermankirin\u00ea dibe al\u00eekar, nemaze dema ku test\u00ean xw\u00een\u00ea y\u00ean periyod\u00eek (Biyopsiya \u015eile) t\u00eane bikar an\u00een.<\/li>\n\n\n\n<li>Ew pence\u015f\u00ear\u00ean m\u00eeras\u00ee y\u00ean z\u00fb tesp\u00eet dike, \u00fb r\u00ea dide destwerdana p\u00ea\u015f\u00eel\u00eagirtin\u00ea.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">3. T\u00eaketina ceribandin\u00ean kl\u00een\u00eek\u00ee (<a href=\"https:\/\/www.cancer.gov\/research\/participate\/clinical-trials\" target=\"_blank\" rel=\"noopener\">Ceribandin\u00ean Kl\u00een\u00eek\u00ee<\/a>):<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Gelek derman\u00ean n\u00fb y\u00ean sozdar di ceribandin\u00ean kl\u00een\u00eek\u00ee de xwe disp\u00earin hedefgirtina mutasyon\u00ean gen\u00ean taybet\u00ee. Encam\u00ean ceribandina genet\u00eek\u00ee ji bo \u015fertkirina nexwe\u015fan ji bo van ceribandinan gir\u00eeng in, ji ber ku ew gih\u00ee\u015ftina dermankirin\u00ean p\u00ea\u015fkeft\u00ee ber\u00ee ku ew di bazirganiy\u00ea de peyda bibin didin wan.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">4. Te\u015fh\u00eesa rast:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ew te\u015fh\u00eesek rasttir a curey\u00ea tumor \u00fb dabe\u015fkirina w\u00ea ya biyoloj\u00eek\u00ee ya molekul\u00ee dide, dabe\u015fkirinek ku di gelek rew\u015fan de ji dabe\u015fkirina h\u00eestoloj\u00eek a kevne\u015fop\u00ee gir\u00eengtir b\u00fbye.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Zehmetiy\u00ean anal\u00eeza genet\u00eek\u00ee \u00fb \u015f\u00eerovekirina kl\u00een\u00eek\u00ee<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Tev\u00ee p\u00ea\u015fketina mezin, sepandina ceribandina genet\u00eek\u00ee bi hin pirsgir\u00eakan re r\u00fb bi r\u00fb dim\u00eene ku zanyar \u00fb bij\u00ee\u015fk ji bo derbaskirina wan dixebitin:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. Nehevsengiya tumor\u00ea:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ne hem\u00fb \u015faney\u00ean di tumorek\u00ea de ji h\u00eala genet\u00eek\u00ee ve yek in. Biyops\u00eeyek ji deverek yekane hat\u00ee girtin dibe ku w\u00eaney\u00ea genet\u00eek\u00ee y\u00ea tevah\u00ee y\u00ea tumor an metastaz\u00ean w\u00ea tems\u00eel neke. Ev yek ji wan sedeman e ku \u00e7ima biyopsiya \u015file ji bo \u00e7areserkirina v\u00ea nehevsengiy\u00ea hat\u00ee p\u00ea\u015fve xistin.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2. Mutasyon\u00ean bi gir\u00eengiya nediyar (VUS):<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Carinan, pi\u015fkin\u00een mutasyon\u00ean ku rola wan a kl\u00een\u00eek\u00ee an patoloj\u00eek h\u00een bi tevah\u00ee nehatiye destn\u00ee\u015fankirin tesp\u00eet dike (Guhertoy\u00ean Gir\u00eengiya Nediyar). \u015e\u00eerovekirina van mutasyonan hewldanek berbi\u00e7av \u00fb \u00e7avd\u00eariya daney\u00ean gerd\u00fbn\u00ee y\u00ean n\u00fbjen hewce dike.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3. Mesref \u00fb s\u00eegorta:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Mesrefa ceribandina genet\u00eek\u00ee ya berfireh (NGS) dikare z\u00eade be, \u00fb ne hem\u00ee pergal\u00ean s\u00eegortaya tenduristiy\u00ea bi tevah\u00ee w\u00ea vedigirin, her \u00e7end l\u00ea\u00e7\u00fbna dermankirina b\u00eabandor pir caran ji l\u00ea\u00e7\u00fbna ceribandina genet\u00eek\u00ee z\u00eadetir be.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Kurte \u00fb perspekt\u00eef\u00ean p\u00ea\u015feroj\u00ea y\u00ean \u015fopa tiliy\u00ean genet\u00eek\u00ee<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">**\u015eopandina tiliy\u00ean genet\u00eek\u00ee** di deh sal\u00ean daw\u00ee de gaveke gir\u00eeng \u00fb ne\u00e7ar e di te\u015fh\u00ees \u00fb plansaziya dermankirin\u00ea ya pence\u015f\u00ear\u00ea de. Em ji modela &quot;yek-size-fits-all&quot; derbas\u00ee modela **derman\u00ea kesane y\u00ea rast** b\u00fbne, ku biryar\u00ean dermankirin\u00ea li gor\u00ee prof\u00eela genet\u00eek\u00ee ya b\u00eahempa ya her nexwe\u015fek\u00ee t\u00eane day\u00een.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ev muayeneya p\u00ea\u015fket\u00ee ne ten\u00ea ji bo t\u00eagih\u00ee\u015ftina rast a cewher\u00ea tumor\u00ea \u00fb hilbijartina dermankirina her\u00ee guncaw \u00fb bibandor dibe al\u00eekar, l\u00ea di heman dem\u00ea de rasterast be\u015fdar\u00ee ba\u015ftirkirina \u015fans\u00ean ba\u015fb\u00fbn\u00ea \u00fb k\u00eamkirina bar\u00ea dermankirina nehewce dibe. Her ku ceribandina genet\u00eek\u00ee ya nif\u015f\u00ea p\u00ea\u015feroj\u00ea (NGS) berdewam dike \u00fb nif\u015f\u00ean n\u00fb y\u00ean terapiy\u00ean hedefgirt\u00ee derdikevin hol\u00ea, rola gir\u00eeng a anal\u00eeza genet\u00eek\u00ee ya tumor\u00ea d\u00ea berdewam bike mezin bibe, \u00fb bibe h\u00eaviya her\u00ee mezin ji bo nexwe\u015f \u00fb bij\u00ee\u015fkan di \u015fer\u00ea wan \u00ea li dij\u00ee pence\u015f\u00ear\u00ea de.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Eger h\u00fbn an endamek\u00ee malbata we bi te\u015fh\u00eesa pence\u015f\u00ear\u00ea re r\u00fb bi r\u00fb bin, \u015f\u00eawir\u00eena bi onkolog re li ser derbaskirina ceribandineke genet\u00eek\u00ee ya berfireh gava yekem \u00fb her\u00ee gir\u00eeng e ji bo ku h\u00fbn pi\u015ftrast bin ku h\u00fbn vebijark\u00ean dermankirina armanckir\u00ee y\u00ean \u00e7\u00eatir\u00een \u00fb rasttir\u00een \u00ean li \u00e7araliy\u00ea c\u00eehan\u00ea hene bist\u00eenin.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/auxsupport.com\/wp-content\/uploads\/2021\/09\/cat-14.jpg\" alt=\"T\u00fbr\u00eezma bij\u00ee\u015fk\u00ee li Urdun\u00ea\" class=\"wp-image-1770\" title=\"\"><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>\u0627\u0644\u0645\u0642\u062f\u0645\u0629 \u0641\u064a \u0639\u0635\u0631 \u0627\u0644\u0637\u0628 \u0627\u0644\u0634\u062e\u0635\u064a\u060c \u0644\u0645 \u064a\u0639\u062f \u0627\u0644\u062a\u0639\u0627\u0645\u0644 \u0645\u0639 \u0645\u0631\u0636 \u0627\u0644\u0633\u0631\u0637\u0627\u0646 \u064a\u0639\u062a\u0645\u062f \u0639\u0644\u0649 \u0627\u0644\u062a\u0634\u062e\u064a\u0635 \u0627\u0644\u0633\u0631\u064a\u0631\u064a \u0648\u062d\u062f\u0647. \u0644\u0642\u062f \u0623\u062d\u062f\u062b\u062a \u0627\u0644\u062a\u0637\u0648\u0631\u0627\u062a \u0641\u064a \u0639\u0644\u0648\u0645 \u0627\u0644\u062c\u064a\u0646\u0648\u0645 \u0648\u0627\u0644\u0648\u0631\u0627\u062b\u0629 \u062b\u0648\u0631\u0629 \u062d\u0642\u064a\u0642\u064a\u0629\u060c \u062d\u064a\u062b \u0623\u0635\u0628\u062d \u0641\u062d\u0635 \u0627\u0644\u0628\u0635\u0645\u0629 \u0627\u0644\u062c\u064a\u0646\u064a\u0629 \u0623\u0648 \u0645\u0627 \u064a\u064f\u0639\u0631\u0641 \u0628\u0640 **\u0627\u0644\u0641\u062d\u0635 \u0627\u0644\u062c\u064a\u0646\u064a \u0644\u0644\u0633\u0631\u0637\u0627\u0646** \u0645\u0646 \u0623\u0647\u0645 \u0648\u0623\u062d\u062f\u062b \u0627\u0644\u0623\u0633\u0627\u0644\u064a\u0628 \u0627\u0644\u0637\u0628\u064a\u0629 \u0641\u064a \u0639\u0627\u0644\u0645 \u062a\u0634\u062e\u064a\u0635 \u0648\u0639\u0644\u0627\u062c \u0627\u0644\u0623\u0648\u0631\u0627\u0645. \u064a\u0639\u062a\u0645\u062f \u0647\u0630\u0627 \u0627\u0644\u0641\u062d\u0635 \u0639\u0644\u0649 \u062a\u062d\u0644\u064a\u0644 \u0627\u0644\u062d\u0645\u0636 \u0627\u0644\u0646\u0648\u0648\u064a (DNA) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4239,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"two_page_speed":[],"footnotes":""},"categories":[506],"tags":[499,505,500,504,502,501,503],"class_list":["post-4238","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-506","tag-499","tag-505","tag-500","tag-504","tag-502","tag-501","tag-503"],"_links":{"self":[{"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/posts\/4238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/comments?post=4238"}],"version-history":[{"count":0,"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/posts\/4238\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/media\/4239"}],"wp:attachment":[{"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/media?parent=4238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/categories?post=4238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/auxsupport.com\/ku\/wp-json\/wp\/v2\/tags?post=4238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}